Citigroup reaffirmed a neutral rating on AvePoint, and insider transactions involving the company were disclosed to the SEC.
2 reports, 1 independent
Updated Fri 00:00
No new developments lately
- Reports
- 2
- Developments
- 1
- Repetition
- 50%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Citigroup reaffirmed a neutral rating on AvePoint, and insider transactions involving the company were disclosed to the SEC.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Citigroup
American investment bank and financial services corporation
-
AvePoint
American software vendor
-
SEC
Slovak company
Related events
- Citigroup reiterated a neutral rating on Olin stock.
- Citigroup reiterated an 'outperform' rating on Ouster shares, alongside insider trading disclosures filed with the SEC.
- Delek US filed a transaction disclosure with the SEC on August 1, 2026, concurrent with Citigroup reiterating a neutral rating on the company's shares.
- Anixa Biosciences disclosed an insider purchase via SEC filing, coinciding with MarketBeat price target changes and a buy rating restatement from Citigroup.
- Citigroup restated a neutral rating on Rapid7 shares, and Scotiabank upped its price target for the company.